BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38411349)

  • 1. Correction to: HDAC5, Negatively regulated by miR- 148a- 3p, promotes colon cancer cell migration.
    Cancer Sci; 2024 Apr; 115(4):1361. PubMed ID: 38411349
    [No Abstract]   [Full Text] [Related]  

  • 2. HDAC5, negatively regulated by miR-148a-3p, promotes colon cancer cell migration.
    OuYang C; Shu G; Liu J; Deng S; Lu P; Li Y; Gan Y; Xie B; Liu J; Yin G
    Cancer Sci; 2022 Aug; 113(8):2560-2574. PubMed ID: 35574707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hsa-miR-148a-3p promotes malignant behavior of breast cancer cells by downregulating DUSP1].
    Xu J; Lin L; Chen Q; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1515-1524. PubMed ID: 37814866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-148a-3p inhibits the proliferation and migration of bladder cancer
    Xu C; Zhou G; Sun Z; Zhang Z; Zhao H; Jiang X
    PeerJ; 2022; 10():e12724. PubMed ID: 35127282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PVT1 facilitates cell migration and invasion by regulating miR-148a-3p and ROCK1 in breast cancer.
    Li HL; Wang CP; Zhang Y; Du JX; Han LH; Yang HY
    Clin Transl Oncol; 2022 May; 24(5):882-891. PubMed ID: 34859371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
    Su H; Fan G; Huang J; Qiu X
    Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.
    Sun J; Yin A; Zhang W; Lv J; Liang Y; Li H; Li Y; Li X
    Cell Transplant; 2020; 29():963689720925751. PubMed ID: 32425115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_HIPK3 Knockdown Inhibits Cell Proliferation, Migration and Invasion of Cholangiocarcinoma Partly via Mediating the miR-148a-3p/ULK1 Pathway.
    You J; Wang X
    Cancer Manag Res; 2021; 13():3827-3839. PubMed ID: 34007215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11.
    Martino E; Balestrieri A; Aragona F; Bifulco G; Mele L; Campanile G; Balestrieri ML; D'Onofrio N
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575.
    Shang L; Quan A; Sun H; Xu Y; Sun G; Cao P
    Gene; 2019 Aug; 711():143948. PubMed ID: 31255737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA
    Li H; Hong J; Wijayakulathilaka WSMA
    Cell Cycle; 2019 Dec; 18(23):3313-3324. PubMed ID: 31590627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma.
    Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z
    Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA KIF9-AS1 promotes cell apoptosis by targeting the microRNA-148a-3p/suppressor of cytokine signaling axis in inflammatory bowel disease.
    Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e922-e932. PubMed ID: 34750325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl Inhibits Lung Cancer Viability and Invasion via Upregulation of miR-331-3p and Repression of HDAC5.
    Gong S; Ying L; Fan Y; Sun Z
    Onco Targets Ther; 2020; 13():13131-13141. PubMed ID: 33380803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.
    Liang L; Xu WY; Shen A; Cen HY; Chen ZJ; Tan L; Zhang LM; Zhang Y; Fu JJ; Qin AP; Lei XP; Li SP; Qin YY; Huang JH; Yu XY
    Acta Pharmacol Sin; 2022 Nov; 43(11):2946-2955. PubMed ID: 35388129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer.
    Bao C; Guo L
    J Clin Lab Anal; 2020 Oct; 34(10):e23454. PubMed ID: 32785967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.
    Chen Q; Wang Y; Dang H; Wu X
    Oncol Lett; 2021 Aug; 22(2):617. PubMed ID: 34257725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.